TREATMENT OF A CANCER USING A COMBINATION OF BENDAMUSTINE AND AN ANTI-CD20 ANTIBODY
摘要
<p>Disclosed is the use of bendamustine in combination with an anti-CD20 antibody to treat cancer. The combination can be administered separately, sequentially and/or simultaneously. Pharmaceutical compositions and medicament are also disclosed.</p>